Facial Injectable Market Worth 25.82 Billion by 2027 at a 8.86% CAGR

17 Nov 2021

Facial Injectable Market is valued at USD 14.25 Billion in 2020 and is expected to reach USD 25.82 Billion by 2027 with a CAGR of 8.86% over the forecast period.  Increasing demand to enhance the aesthetic beauty and rising preference for minimally invasive procedures are some of the major factors driving the growth of the Global Facial Injectable Market.

Request Premium Sample of the Report: https://brandessenceresearch.com/requestSample/PostId/658


Scope of Facial Injectable Market:

Amplified products such as BoNTA (Botulinum Toxin Type A) and HA (Hyaluronic Acid) fillers are used in combination to improve results, specifically in the lower face procedures. This boosts the growth of global facial injectable market.

Rising awareness of beauty all over the world is demanding for the increased usage of dermal fillers and other facial injectable. Some of the trending employments of facial injectable include facial rejuvenation & bio-engineering of the facial skin, increasing scar depressions, and many other. Even if the surgical rejuvenation has been the choice of therapy by consumers, doctors nowadays are selecting facial dermal fillers as compared to surgical processes, for example, facelift. This, in turn, powers the global market for facial injectables. Most of the methods have been rolled out for facial rejuvenation earlier. Besides all these, collagen injections are being used for a long time to cure facial imperfections.


Recent Developments:

News:  Restylane Contour Received FDA Approval

On June 29th, 2021; Galderma declared the FDA endorsement of Restylane Contour for cheek expansion and amendment of midface contour lacks in grown-ups 21 years or older. The new hyaluronic acid (HA) filler is Galderma's just item in the United States planned with XpresHAn Technology for the cheek.

Increasing Demand to Enhance the Aesthetic Beauty and Rising Preference for Minimally Invasive Procedures are Driving the Market Growth

As the facial injectables are used in the therapeutic procedures for volumizing lips & cheeks and reduce wrinkles by injecting directly into them as it relaxes the muscles that create wrinkles. Also as wrinkles are one of the signs of ageing, and many of the early age patients and male patients population are opting for aesthetic procedures like lip augmentation, face lift, acne treatment, scars treatment and aesthetic procedures. These are the most common type of facial aesthetic procedures require facial injectable. Thus, the growing elderly population and increasing demand to enhance the aesthetic beauty are leading the increased adoption of facial injectable.

In addition, the increasing shift towards the minimally invasive procedures are also supplementing the market growth. For instance; according to the American Society of Plastic Surgeons (ASPS), in U.S. about 17.7 million minimally invasive and surgical cosmetic products were performed in 2018 in which nearly about 15.9 million products were minimally invasive. Thus, the increasing adoption of minimally invasive surgeries, which are combined with the availability of a wide range of such facial injectables treatment options, are also driving the market for facial injectables.

However, the side effects of undertaking the cosmetic surgeries or various facial surgeries which also involve the usage of facial injectables may hamper the growth of the market. In spite of that, the rising interest in physical appearance along with an increase in disposable income among the middle-class population in developing countries may create more opportunities for the further growth of the market.

Facial Injectable Manufacturers:

Some key players for global Facial Injectable Market Ipsen, Merz Pharma, ALLERGAN, Medytox, Inc., Suneva Medical, Inc., Bloomage BioTechnology Corporation Limited, Sinclair Pharma, Prollenium Medical Technologies Inc., Anika Therapeutics, Inc., Galderma S.A. & Others

Facial Injectable Market Segments:

By Type:

Dermal Fillers/Injectable Implants (Hyaluronic Acid, Collagen Fillers, Synthetic Fillers),

Anti-aging/ Anti-wrinkle Injections (Botulinum Toxin A, Poly-L-Lactic Acid (PLLA) Micro Particles)

By End-User:

Hospitals

Dermatology Clinics

Beauty Clinics

Dermatology Research Institutes

North America Had Utmost Share Of The Facial Injectable Market Due To Elevated Investment On Aesthetic Procedures

North America had more than 40% share of the facial injectables market due to elevated investment on aesthetic procedures. Moreover, attendance of a huge elderly population base in Canada and the US is predicted to power the requirement for injectables during the coming period. As per predictions offered in the year 2014 by the United States Census Bureau, the elderly population in the US is expected to cross 84 million by 2050 in comparison to the population of 44 million in 2012. Moreover, the 2016 Population Reference Bureau report predicted that elderly population in the area is predicted to rise and reach from 46.0 million in 2016 to 99 million by 2060. Europe is also predicted to have considerable market share over the coming period due to rising user disposable revenue paired with the attendance of extremely enhanced healthcare manufacturers and infrastructure.

Request Methodology of the Report: https://brandessenceresearch.com/requestMethodology/PostId/658

 

About us: Brandessence Market Research and Consulting Pvt. ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact us at: +44-2038074155 or mail us at sales@brandessenceresearch.com

Share on: